Olympus Corporation
Monolith, 3-1 Nishi-Shinjuku 2-chome
Shinjuku-ku
Tokyo
163-0914
Tel: 81-3-3340-2111
Fax: 81-3-3340-2062
Website: http://www.olympus.co.jp/
241 articles about Olympus Corporation
-
iTind™ Procedure Available to More Patients through Extended Commercial Payer Coverage
4/16/2024
Olympus announced positive changes to commercial payer policies covering patients who could benefit from the iTind™ procedure, a minimally invasive treatment for the lower urinary tract symptoms caused by benign prostatic hyperplasia, also known as enlarged prostate.
-
Olympus Awarded PROVISTA Contract for Advanced Energy Portfolio
3/29/2024
Olympus announced that it has been awarded a contract for its advanced energy portfolio by Provista Inc.
-
Olympus Announces iTind™ Treatment Milestone with Availability Through Major GPOs
3/28/2024
Olympus announced a milestone for its iTind™ device with its availability and greater patient access through the largest healthcare group purchasing organization contracts in the United States.
-
Olympus Corporation of the Americas' Julien Sauvagnargues Steps into CEO Role
3/27/2024
Olympus announced the appointment of Julien Sauvagnargues to the role of President and Chief Executive Officer, Olympus Corporation of the Americas, reporting to Olympus Chief Strategy Officer, Gabriela Kaynor, effective April 1, 2024.
-
Olympus Partners with American Lung Association on Patient Education for Lung Cancer Screening
3/27/2024
Olympus Corporation of the Americas, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, is now partnering with the American Lung Association to educate lung cancer patients about the care pathway for diagnosing and staging lung nodules.
-
Get Screened: Top Message from Colorectal Cancer Surgeon and Patient
3/25/2024
Colorectal cancer is highly preventable with screening. Furthermore, localized colorectal cancer has a 91% five-year survival rate with treatment.i.
-
Spring Holiday Season: Olympus Reminds Families of Swallowing Hazards
3/21/2024
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, is reminding families about the common swallowing hazards that could be hiding in their child's Easter basket, on their Passover dinner plate, or among their Eid al-Fitr celebrations.
-
Olympus and the Colorectal Cancer Alliance Offer a Reminder About the Importance of Preventive Cancer Screenings
3/5/2024
As the American Cancer Society reports an increase in death rates from colorectal cancer for patients under the age of 50, Olympus Corporation of the Americas and the Colorectal Cancer Alliance offer a reminder about the importance of preventive screenings and knowing your family health history.
-
Olympus Distribution of EndoClot® Showing Steady Adoption in the U.S.
3/1/2024
Olympus announced that EndoClot products are now used in 49 of the 50 U.S. states as well as the District of Columbia and Guam, since Olympus became the exclusive U.S. distributor of EndoClot hemostatis and submucosal injection solution technologies in 2022.
-
Olympus Earns High Marks in Human Rights Campaign Foundation's Corporate Equality Index
1/17/2024
Olympus Corp. of the Americas, a global medical technology company, announced that it received a score of 90 out of 100 on the Human Rights Campaign Foundation's 2023-24 Corporate Equality Index.
-
Olympus Names New Global General Counsel, Neil Boyden Tanner
12/19/2023
Olympus announced the appointment of Neil Boyden Tanner, Esq. as Global General Counsel of Olympus Corporation, reporting to Stefan Kaufmann, President and Chief Executive Officer.
-
Olympus Issues Voluntary Field Action to Remind Users of Warnings for Bronchoscopes Used with High-Frequency Therapy Equipment
11/9/2023
Olympus Corporation has announced a voluntary field corrective action to address complaints of endobronchial combustion occurring during therapeutic procedures involving use of high-frequency therapy equipment in an oxygenated environment.
-
Olympus Issues Request to Discontinue Use of UHI-4 Insufflator Unit, Except in Cases Where No Alternative is Available
10/27/2023
Olympus Corporation has announced a field corrective action in the U.S. to address complaints of adverse events from over insufflation during use of the high-flow insufflation unit UHI-4.
-
Olympus Announces Two New Category I CPT Codes for the iTind Procedure
10/20/2023
Olympus Corporation announced that the American Medical Association will issue two new Category I Current Procedural Terminology codes for the iTind™ procedure, a minimally invasive treatment for men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
-
Novel iTind Procedure Now Included in Treatment Guideline for Lower Urinary Tract Symptoms Caused by Enlarged Prostate
9/28/2023
Olympus Corporation announced that its iTind™ procedure is now included in the American Urological Association clinical practice guideline for management of lower urinary tract symptoms attributed to benign prostatic hyperplasia, also known as enlarged prostate.
-
Olympus Adopts AcuityMD Across the Enterprise to Power an Expanding Omnichannel Engagement Strategy
9/12/2023
AcuityMD has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals.
-
Olympus Announces Launch of Newest Systems Integration Solution - July 25, 2023
7/25/2023
Olympus Corporation announced U.S. market availability of EASYSUITE™ ES-IP system, its newest procedure room visualization and integration solution.
-
Olympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
7/3/2023
Olympus Corporation has announced a voluntary field corrective action to address complaints of endobronchial combustion occurring when laser-compatible bronchoscopes are used during therapeutic procedures in combination with laser therapy equipment or argon plasma coagulation.
-
Olympus Announces Launch of Next Generation Electrosurgical Generator
6/6/2023
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced market availability of its newest electrosurgical generator for use in the treatment of bladder cancer and enlarged prostate.
-
Olympus Set to Demonstrate Newest Endoscopy System at DDW
5/4/2023
Olympus Corporation announced that, for the first time in the U.S., it will demonstrate the EVIS X1™ endoscopy system, its most advanced endoscopy system, at the Digestive Disease Week annual meeting May 6-9 in Chicago.